Abbott Laboratories (ABT)

Total Costs & Expenses

$40.88B

TTM · Period ending: · USD

ABT logo

ABT Total Costs & Expenses

Latest reported$40.88B
ABT TTM Total Costs & Expenses ($2.93B → $40.88B)
High-resolution chart · PNG

ABT total costs & expenses history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Abbott Laboratories Total Costs & Expenses — Trailing twelve months (TTM) (USD)
Period endingTotal Costs & Expenses (USD)
40,878,000,000
38,653,000,000
36,932,000,000
36,280,000,000
36,056,000,000
35,561,000,000
35,162,000,000
35,071,000,000
34,464,000,000
34,112,000,000
33,888,000,000
33,656,000,000
33,929,000,000
34,171,000,000
34,628,000,000
35,291,000,000
35,662,000,000
35,261,000,000
34,562,000,000
33,875,000,000
33,141,000,000
32,232,000,000
30,693,000,000
29,317,000,000
27,939,000,000
27,416,000,000
27,519,000,000
27,348,000,000
27,028,000,000
26,760,000,000
26,791,000,000
26,734,000,000
26,999,000,000
26,317,000,000
25,746,000,000
25,428,000,000
22,932,000,000
21,392,000,000
19,660,000,000
17,620,000,000
17,635,000,000
17,688,000,000
17,612,000,000
17,538,000,000
17,628,000,000
17,542,000,000
17,481,000,000
17,584,000,000
17,507,000,000
17,508,000,000
17,947,000,000
18,320,000,000
22,327,613,000
25,759,613,000
28,643,292,000
31,761,203,000
31,662,575,000
33,100,575,000
33,240,734,000
33,099,524,000
32,942,440,000
31,214,440,000
30,516,602,000
29,003,901,000
27,622,391,000
26,249,391,000
24,928,391,000
24,359,000,000
23,809,981,000
23,790,124,000
23,795,004,000
23,736,457,000
23,232,435,000
22,581,444,000
21,936,820,000
21,335,693,000
22,104,234,000
21,538,686,000
21,312,777,000
20,434,103,000
18,708,744,000
18,360,324,000
17,830,862,000
17,958,409,000
17,737,134,000
16,851,983,000
16,329,689,000
15,773,596,000
15,673,059,000
15,956,868,000
16,448,771,000
16,358,029,000
15,883,760,000
15,376,755,000
14,610,051,000
14,154,522,000
13,791,116,000
13,799,830,000
13,668,647,000
14,247,814,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.